Genomics Services Market Expected to Hit USD 16.2 Billion by 2035 at 9.2% CAGR

Wilmington, DE, USA, 11th May 2026 - According to MarketGenics, the global genomics services market is valued at USD 6.7 billion in 2025 and is projected to reach approximately USD 16.2 billion by 2035, expanding at a CAGR of 9.2% during the forecast period. Growth is primarily driven by increasing adoption of precision medicine, rising demand for next-generation sequencing (NGS), expanding genomic research activities, and growing applications of genomics in diagnostics, oncology, and personalized healthcare.

For biotechnology companies, pharmaceutical firms, hospitals, and research institutions, the market is evolving toward AI-enabled genomic analytics, high-throughput sequencing services, and scalable bioinformatics platforms that improve diagnostic accuracy, accelerate drug discovery, and support personalized treatment strategies.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables): https://marketgenics.co/reports/genomics-services-market-15410

==============================
MARKET HIGHLIGHTS:
==============================

• Sequencing services dominate with nearly 70% market share, driven by growing adoption of next-generation sequencing technologies in research and clinical diagnostics

• North America leads the market with approximately 47% share, supported by advanced healthcare infrastructure and strong investments in genomic research

• Top five players account for nearly 70% of the global market, reflecting a highly consolidated competitive landscape

• AI-enabled genomic data analysis and precision medicine applications are transforming genomics services globally

==============================
MARKET OVERVIEW - KEY STATISTICS:
==============================

Drivers - Rising Demand for Precision Medicine and Genomic Diagnostics

The increasing demand for personalized healthcare and genomic diagnostics is a major driver for the genomics services market. Genomics technologies enable faster and more accurate detection of genetic disorders, cancer mutations, and rare diseases, supporting tailored treatment approaches across healthcare systems.

Key Fact: Next-generation sequencing (NGS) technologies are now used in more than 60% of genomic analyses worldwide due to improved speed, cost efficiency, and analytical accuracy.

Challenges - High Sequencing Costs and Data Privacy Concerns

Despite rapid technological advancements, genomic sequencing and bioinformatics infrastructure require substantial investment, limiting adoption in price-sensitive and developing markets. In addition, concerns related to genetic data privacy, regulatory compliance, and ethical handling of sensitive patient information continue to challenge broader market expansion.

Get Sample copy of the Report: https://marketgenics.co/download-report-sample/genomics-services-market-15410

==============================
EMERGING MARKET OPPORTUNITIES:
==============================

~USD 4.5 Billion

Attractive opportunity by

North America

during the forecast period (2025-2035)

The market opportunity is strongest in North America due to rising investments in precision medicine, increasing adoption of genomic diagnostics, and strong government and private sector funding for genomic research. The region's advanced healthcare infrastructure and expanding biotechnology ecosystem continue to accelerate market growth.

==============================
SEGMENTAL FOCUS:
==============================

Market Share by Type of Service (2025)

Sequencing Services - 70%

Microarray Services

Bioinformatics Services

Others

The sequencing services segment accounts for nearly 70% of the global genomics services market in 2025 due to increasing demand for high-throughput genomic analysis, personalized medicine, and molecular diagnostics.

Sequencing services are extensively used across oncology research, inherited disease testing, drug discovery, and clinical diagnostics where accurate genomic interpretation and rapid analysis are essential.

==============================
REGIONAL INSIGHTS - GLOBAL GROWTH ANCHORS:
==============================

North America dominates the global genomics services market, supported by strong research infrastructure, rising healthcare investments, advanced sequencing capabilities, and growing adoption of precision medicine technologies.

==============================
REGIONAL SHARE ANALYSIS, 2025:
==============================

United States - Major Share

Canada

Europe

Asia Pacific

==============================
KEY TECHNOLOGY TRENDS:
==============================

AI-powered genomic analytics and next-generation sequencing platforms are becoming increasingly important across healthcare and life sciences industries. Advanced machine learning algorithms enable faster interpretation of complex genomic datasets, improving diagnostic precision and accelerating drug discovery workflows.

Companies are also investing in automated sample preparation systems, cloud-based bioinformatics platforms, liquid biopsy technologies, and secure genomic data management solutions to improve operational efficiency and scalability.

==============================
HIGH GROWTH COUNTRY:
==============================

United States is expected to witness the fastest growth, driven by expanding genomic research programs, increasing precision medicine adoption, rising cancer diagnostics demand, and strong investments from biotechnology and pharmaceutical companies.

==============================
COMPETITIVE LANDSCAPE - TECHNOLOGY AND SCALE DRIVEN:
==============================

The global genomics services market is highly consolidated, with the top five players accounting for nearly 70% of market share. Major companies including Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, QIAGEN N.V., and Eurofins Scientific continue to invest in high-throughput sequencing technologies, AI-driven bioinformatics platforms, and global genomics infrastructure to strengthen market leadership.

==============================
KEY PLAYERS OPERATING IN THE GLOBAL GENOMICS SERVICES MARKET:
==============================

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• F. Hoffmann-La Roche Ltd

• QIAGEN N.V.

• Eurofins Scientific

• Agilent Technologies, Inc.

• BGI Group

• Oxford Nanopore Technologies

• Macrogen Inc.

• Novogene Co., Ltd.

• MedGenome Labs Ltd.

• Veritas Genetics

• CD Genomics

• CosmosID

• Other Key Players

==============================
COMPANY INSIGHTS:

==============================
ILLUMINA, INC.:
==============================

Company Focus

Next-generation sequencing technologies and genomic analytics

Headquarters

United States

Innovation Highlights

In 2025, Illumina continued expanding its high-throughput sequencing portfolio with advanced AI-enabled genomic analysis solutions designed to improve speed, scalability, and clinical accuracy.

==============================
EUROFINS SCIENTIFIC:
==============================

Company Focus

Genomics testing and bioinformatics services

Headquarters

Luxembourg

Innovation Highlights

In September 2025, Eurofins Scientific expanded its genomics services portfolio by launching high-throughput whole-genome sequencing solutions featuring enhanced data analytics and secure digital tracking capabilities.

==============================
RECENT STRATEGIC DEVELOPMENTS INCLUDE:
==============================

In August 2025, Agilent Technologies, Inc. launched a new suite of automated genomic sample preparation kits aimed at improving speed and accuracy in next-generation sequencing workflows through integrated barcoding technology.

In September 2025, Eurofins Scientific introduced high-throughput whole-genome sequencing solutions designed to deliver faster turnaround times, improved genomic data integrity, and scalable sequencing capabilities for clinical and research applications.

==============================
THE GLOBAL GENOMICS SERVICES MARKET HAS BEEN SEGMENTED AS FOLLOWS:
==============================

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY TYPE OF SERVICE:

• Sequencing Services

• Microarray Services

• Bioinformatics Services

• Others (e.g., PCR, NGS Library Preparation)

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY TECHNOLOGY:

• Next-Generation Sequencing (NGS)

• Sanger Sequencing

• Microarray

• PCR

• Others

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY RESEARCH TYPE:

• Functional Genomics

• Epigenomics

• Metagenomics

• Transcriptomics

• Proteomics

• Others

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY MODE OF DELIVERY:

• On-site Services

• Off-site Services

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY BUSINESS MODEL:

• Outsourced Services

• In-house Services

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY APPLICATION:

• Drug Discovery and Development

• Diagnostics

• Agriculture and Animal Research

• Personalized Medicine

• Others

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY END USER:

• Hospitals and Clinics

• Academic and Research Institutions

• Pharmaceutical and Biotechnology Companies

• Diagnostic Laboratories

• Others

GLOBAL GENOMICS SERVICES MARKET ANALYSIS, BY REGION:

• North America

• Europe

• Asia Pacific

• Middle East

• Africa

• South America

==============================
RESEARCH METHODOLOGY:
==============================

This report is based on a comprehensive research methodology combining primary interviews with biotechnology companies, genomic service providers, healthcare professionals, and research institutions, along with secondary research from scientific publications, company reports, healthcare databases, and regulatory sources.

Advanced forecasting models, market triangulation techniques, and statistical analysis tools were used to ensure accurate market projections and reliable strategic insights.

==============================
FUTURE OUTLOOK & STRATEGIC RECOMMENDATIONS:
==============================

The genomics services market is expected to witness strong long-term growth as healthcare systems increasingly adopt precision medicine and genomic diagnostics. Rising applications in oncology, rare disease research, drug discovery, and predictive healthcare will continue driving demand for advanced sequencing and bioinformatics services.

Companies investing in AI-powered genomic analytics, scalable sequencing infrastructure, cloud-based bioinformatics platforms, and secure genomic data management technologies are expected to lead the next phase of market expansion.

GET 10% FREE CUSTOMISATION: https://marketgenics.co/get-10-percent-free-customisation

==============================
RECOMMENDED REPORTS:
==============================

AI in Healthcare Market: https://marketgenics.co/reports/ai-in-healthcare-market-64804

Telehealth Market: https://marketgenics.co/reports/telehealth-market-26979

Contact:

Mr. Debashish Roy

MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

About MarketGenics

MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.

MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.

In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.

This release was published on openPR.